AKT1 and metabolic dysfunction-associated steatotic liver disease: Further investigation highlighted that the Hippo pathway interacts with the AKT pathway by influencing insulin receptor substrate 2 (IRS2) expression in NAFLD, which affects the development of NAFLD and even HCC [11].